4.6 Editorial Material

The Impact of Preclinical Irreproducibility on Drug Development

Related references

Note: Only part of the references are listed.
Article Oncology

The Increasing Urgency for Standards in Basic Biologic Research

Leonard P. Freedman et al.

CANCER RESEARCH (2014)

Editorial Material Multidisciplinary Sciences

NIH plans to enhance reproducibility

Francis S. Collins et al.

NATURE (2014)

Editorial Material Medicine, General & Internal

Asia's Ascent - Global Trends in Biomedical R&D Expenditures

Justin Chakma et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Editorial Material Multidisciplinary Sciences

Raise standards for preclinical cancer research

C. Glenn Begley et al.

NATURE (2012)

Review Oncology

Drug development and clinical trials-the path to an approved cancer drug

Eric H. Rubin et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2012)

Article Mathematical & Computational Biology

Tracking replicability as a method of post-publication open evaluation

Joshua K. Hartshorne et al.

FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2012)

Letter Biotechnology & Applied Microbiology

Believe it or not: how much can we rely on published data on potential drug targets?

Florian Prinz et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Environmental Sciences

Minimum Information About a Microarray Experiment (MIAME) - Successes, Failures, Challenges

Alvis Brazma

THESCIENTIFICWORLDJOURNAL (2009)